Bad Times For Breakthrough Drugs Targeting Chemo Complications; Submissions From BMS, Merck

 
• By Bridget Silverman
  
brick wall falling down (Alamy)
Recent review setbacks are a reminder that breakthrough designations involve breaking things. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers